|
RNF150 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04014583005119E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01481062336961E-12 |
| Normal-vs-Stage2 |
2.17936779733918E-12 |
| Normal-vs-Stage3 |
1.4862555630657E-12 |
| Normal-vs-Stage4 |
6.73383571125896E-12 |
| Stage1-vs-Stage2 |
8.053000E-01 |
| Stage1-vs-Stage3 |
8.286600E-01 |
| Stage1-vs-Stage4 |
7.228600E-01 |
| Stage2-vs-Stage3 |
6.714000E-01 |
| Stage2-vs-Stage4 |
6.209200E-01 |
| Stage3-vs-Stage4 |
7.868600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76914038974019E-12 |
| Normal-vs-AfricanAmerican |
3.66573438270734E-12 |
| Normal-vs-Asian |
4.79061235125755E-13 |
| Caucasian-vs-AfricanAmerican |
1.868350E-01 |
| Caucasian-vs-Asian |
6.828300E-04 |
| AfricanAmerican-vs-Asian |
1.996080E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33792976697578E-12 |
| Normal-vs-Female |
5.67668134721089E-12 |
| Male-vs-Female |
5.619700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.74102962549705E-12 |
| Normal-vs-Extreme_Weight |
2.86515255965014E-12 |
| Normal-vs-Obese |
1.51778589696505E-12 |
| Normal-vs-Extreme_Obese |
2.07067696322838E-12 |
| Normal_Weight-vs-Extreme_Weight |
3.966200E-01 |
| Normal_Weight-vs-Obese |
7.889600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.526960E-01 |
| Extreme_Weight-vs-Obese |
3.504200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.100000E-01 |
| Obese-vs-Extreme_Obese |
2.471600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.03035374571436E-12 |
| Normal-vs-Age(41-60Yrs) |
3.37907479774913E-12 |
| Normal-vs-Age(61-80Yrs) |
3.06354941415066E-12 |
| Normal-vs-Age(81-100Yrs) |
2.0069501616149E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.213800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.098200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.663760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.266600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.306200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.707000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.19360077377451E-12 |
| Normal-VS-Type2 PRCC |
7.88147325181399E-13 |
| Normal-VS-KIRP CIMP |
2.37839969940978E-10 |
| Normal-VS-Unclassified PRCC |
4.15834033873352E-12 |
| Type1 PRCC-VS-Type2 PRCC |
9.414800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.785700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.193700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.999700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.789600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.629800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.47193368604803E-12 |
| Normal-vs-N1 |
4.57289761612856E-12 |
| Normal-vs-N2 |
1.058500E-03 |
| N0-vs-N1 |
6.138300E-02 |
| N0-vs-N2 |
5.727000E-01 |
| N1-vs-N2 |
9.857400E-01 |
|
|
